Hikmat A. Al-Ahmadie, MD

About Me

I am a board-certified pathologist in anatomic and clinical pathology with expertise in the surgical pathology of tumors of the genitourinary system. Within our group, every year we examine thousands of biopsies and resections from tumors of the prostate, kidney, bladder, and testis. This enables us to establish the correct diagnosis and the extent of these tumors.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

Of particular academic interest to me are tumors that develop in the urinary bladder. Currently I am researching the molecular and genetic aberrations of these tumors to identify markers that could help with prognosis and treatment decisions. This research is being conducted both in the Department of Pathology as well as through collaborations with other investigators at Memorial Sloan Kettering Cancer Center.

I also serve as one of the principal investigators from Memorial Sloan Kettering in the study of bladder cancer conducted through The Cancer Genome Atlas (TCGA) — a national effort coordinated by the National Cancer Institute and the National Human Genome Research Institute to improve the ability to diagnose, treat, and prevent cancer through a systematic exploration of all genomic changes that occur in human cancers.

See Hikmat A. Al-Ahmadie’s laboratory research at Memorial Sloan Kettering.

  • Clinical Expertise: Oncologic Pathology; Genitourinary Pathology
  • Languages Spoken: English; Arabic; French
  • Education: MD, Damascus University Faculty of Medicine (Syria)
  • Residencies: American University of Beirut; University of Cincinnati College of Medicine
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Anatomic Pathology; Clinical Pathology

See My Colleagues


Visit PubMed for a full listing of Hikmat A. Al-Ahmadie’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.